We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adverse Event Reporting Is Not Postmarket Surveillance
Adverse Event Reporting Is Not Postmarket Surveillance
Part of a strong postmarket surveillance system is a good adverse event reporting system. Any company selling an FDA-regulated product of any kind must have an adverse event reporting system in place, including a database designed to manage the collected reports.